Location History:
- Solingen, DE (2010 - 2018)
- Wuppertal, DE (2007 - 2023)
Company Filing History:
12 out of 721 
4 out of 378 
4 out of 53 
Years Active: 2007-2023
Title: Innovations and Contributions of Mario Jeske in Pharmaceutical Patents
Introduction
Mario Jeske, a prolific inventor based in Solingen, Germany, has an impressive portfolio consisting of 24 patents. His innovative work primarily focuses on pharmaceuticals and their applications in treating various diseases, showcasing his commitment to advancing medical science.
Latest Patents
Among his latest patents, Jeske has developed innovative salts of 1-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-2,4-dioxo-3-[(1R)-4-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid. These include amino acid salts, such as lysine salt, and alkali metal salts, like sodium and potassium salts. His research also encompasses processes for preparation, medicaments derived from these salts, and their applications in controlling diseases. Additionally, he has made significant strides with substituted dihydropyrazolone derivatives aimed at treating cardiovascular and hematological diseases, as well as promoting wound healing. The innovative applications show great potential for enhancing therapeutic strategies in medicine.
Career Highlights
Mario Jeske has contributed to the field of pharmaceuticals through his tenure at Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. His work during this period has enabled him to be at the forefront of pharmaceutical innovations and patent applications, establishing a strong foundation for his patent portfolio.
Collaborations
During his career, Jeske has collaborated with notable professionals in the field, including Friederike Stoll and Hartmut Beck. Their teamwork has facilitated the development of groundbreaking solutions in medication innovation and patent filings, emphasizing the significance of collaboration in scientific advancements.
Conclusion
Mario Jeske's contributions to innovation in pharmaceuticals are marked by his extensive patent portfolio and collaborations with industry experts. His dedication to exploring new applications for existing compounds and the development of novel therapeutic agents underscores the importance of research and its impact on healthcare. His work continues to inspire advancements in treatment methodologies aimed at improving patient outcomes.